Takashi Nomura

Ohiraki, 5530007, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.

Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.

Journal: Journal of medical case reports

Published: November 15, 2023

Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Score Matching.

Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Score Matching.

Journal: Oncology

Published: November 17, 2021

Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

Journal: Oncology

Published: August 06, 2019

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

Journal: World journal of surgical oncology

Published: June 17, 2017

Short-term outcomes following single-port laparoscopic surgery in elderly patients with colon cancer compared with younger patients.

Short-term outcomes following single-port laparoscopic surgery in elderly patients with colon cancer compared with younger patients.

Journal: Oncology letters

Published: February 03, 2017

A case of synchronous sigmoid cancer and ureter cancer

A case of synchronous sigmoid cancer and ureter cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 13, 2015

Single-incision Plus One Port Laparoscopic Total Mesorectal Excision and Bilateral Pelvic Node Dissection for Advanced Rectal Cancer--A Medial Umbilical Ligament Approach.

Single-incision Plus One Port Laparoscopic Total Mesorectal Excision and Bilateral Pelvic Node Dissection for Advanced Rectal Cancer--A Medial Umbilical Ligament Approach.

Journal: International surgery

Published: March 19, 2015

A long-term survivor of a rectal carcinoid treated by use of repeat TACE for multiple intrahepatic recurrences after liver resection and MCT

A long-term survivor of a rectal carcinoid treated by use of repeat TACE for multiple intrahepatic recurrences after liver resection and MCT

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 04, 2015

Two cases of resectable adrenal metastases from hepatocellular carcinoma

Two cases of resectable adrenal metastases from hepatocellular carcinoma

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 04, 2015

Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.

Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.

Journal: International journal of clinical oncology

Published: February 16, 2015

Single-incision plus one-port laparoscopic abdominoperineal resection with bilateral pelvic lymph node dissection for advanced rectal cancer: a case report.

Single-incision plus one-port laparoscopic abdominoperineal resection with bilateral pelvic lymph node dissection for advanced rectal cancer: a case report.

Journal: International surgery

Published: January 17, 2015

Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.

Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.

Journal: Clinical breast cancer

Published: September 18, 2014

Showing 1-12 of 25

Last Updated: 09/26/2026